All News CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Market Closed - OTC Markets Other stock markets 12:29:06 14/05/2024 am IST			5-day change	1st Jan Change
0.009535 ^USD	-6.70%		-6.86%	-33.10%

16/04	CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
12/01	CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14/23/14	CI
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05/23/05	AQ
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02/23/02	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/23/14	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14/23/14	CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08/23/08	AQ
CNBX Pharmaceuticals Inc. Announces Board Resignations	08/23/08	CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/23/13	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13/23/13	CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	30/22/30	AQ
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	30/22/30	CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/22/30	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30/22/30	CI
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30/22/30	CI
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08/22/08	PR
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08/22/08	CI
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18/22/18	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

All News

Filters